Original Articles

Preeclampsia management: different insight from hospital to hospital approach in Indonesia

Firdy Liwang , Agha Bhargah

Firdy Liwang
Faculty of Medicine, Sam Ratulangi University, Manado-Indonesia. Email: firdy.liwang@gmail.com

Agha Bhargah
Faculty of Medicine, Udayana University, Bali-Indonesia
Online First: January 09, 2019 | Cite this Article
Liwang, F., Bhargah, A. 2019. Preeclampsia management: different insight from hospital to hospital approach in Indonesia. Indonesia Journal of Biomedical Science 13(1). DOI:10.15562/ijbs.v13i1.170


Introduction: The incidence of preeclampsia quite high and can cause high morbidity and mortality rates for pregnant women thereby preeclampsia is still a problem experienced worldwide. Preeclampsia in Indonesia still gives a frightening impression for both the mother and the fetus. The key to success in the treatment of preeclampsia is prevention and adequate therapy to reduce morbidity and mortality. Indonesia itself, which is an archipelagic country resulting in far apart geographical location between one central hospital to another central hospital that will cause some differences related to the treatment of preeclampsia itself.

Aim: The purpose of this review is to give an overview of the different approaches to handling preeclampsia in hospitals in Indonesia, especially Sanglah General Hospital Denpasar and Kandou General Hospital Manado.

Conclusion: There are several differences in the treatment of severe preeclampsia at Sanglah General Hospital Denpasar Bali and Prof. Dr. R.D. Kandou Hospital Manado. The differences found were ways to induce labor, use of corticosteroids, detail of MGSO4 administration, and the selection of antihypertensive drugs.

 

References

Khader YS, Batieha A, Al-njadat RA , Hijazi SS. Preeclampsia in Jordan: incidence, risk factors, and its associated maternal and neonatal outcomes. The journal of maternal-fetal & neonatal medicine. 2017;31(6):770-776.

Jameil NA, Tabassum H, Ali MN, Qadeer MA, Khan FA, Rashed MA. Correlation between serum trace elements and risk of preeclampsia: A case controlled study in Riyadh, Saudi Arabia. Saudi Journal of Biological Sciences. 2017;24:1142–1148.

Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vascular Health and Risk Management. 2011;7:467–474.

Vata PK, Chauhan NM, Nallathambi A, Hussein F. Assessment of prevalence of Preeclampsia from Dilla region of Ethiopia. Bio Med Central Res Notes. 2015;8:816-822.

Bej P, Chhabra P, Sharma AK, Guleria K. Determination of Risk Factors for Pre-eclampsia and Eclampsia in a Tertiary Hospital of India: A Case Control Study. Journal of Family Medicine and Primary Care. 2013; 2(4): 371-375.

Wong TY, Gramoen H, Faas MM, Pampus MG. Clinical Risk Factors for Gestational Hypertensive Disorders in Pregnant Women at High Risk for Developing Preeclampsia. International Journal of Women’s Cardiovascular Health. 2013;3:248–253.

English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integrated Blood Pressure Control. 2015;8:7-12.

Kamravamanesh M, Kohan S, Rezavand S, Farajzadegan Z. A comprehensive postpartum follow-up care program for women with history of preeclampsia: protocol for mix method research. Reproductive Health. 2018;15:81-88.

Park HJ, Shim SS, Cha DH. Combined Screening for Early Detection of Pre-Eclampsia. Int. J. Mol. Sci. 2015;16:17952-17974.

Juliantari KB, Sanjaya INH. Characteristics of preeclampsia mother in Sanglah General Hospital 2015. E-Jurnal Medika. 2017;6(4):1-9.

Warouw PC, Suparman E, Wagey FW. Characteristics of preeclampsia in Prof. Dr. R. D. Kandou General Hospital Manado. Jurnal e-Clinic (eCl). 2016;4(1):375-379.

World Health Organisation. Trends in maternal mortality:1990 to 2015. Geneva: WHO Library Cataloguing. 2015. p. 1-4.

Surya IGP, Karkata MK, Kusuma AANJ, Suwardewa TGA, Negara IKS. Operational Standard Protocol Fetomaternal. Department Obstetrics and Gynaecology of Udayana University. 2012.

Warouw NN, Wagey F, Sanger OM, Suparman E, Loho MFT, Sondakh J, et al. Operational Standard Protocol in Obstetric and Gynaecology Departement Prof. Dr. RD. Kandou Hospital Manado. Department Obstetrics and Gynaecology of Sam Ratulangi University. 2013.

Tuffnell DJ, Shennan AH, Waugh JJS, Walker JJ. The Royal College of Obstetricians and Gynaecologists Guideline. England. 2010.

Roberts JM, Druzin M, August PA, Gaiser RR, Bakris, G, Gramanger JP, et al. Hypertension in pregnancy. America: library of congress cataloging. 2013.

Mbizvo M (Director department of reproductive health and research). WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia. Switzerland: WHO Library Cataloguing. 2011.

Magee LA, Helewa M, Moutquin JM, Dadelszen PV, Cardew S, Cote AM, et al. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy. Journal of Obstetrics and Gynaecology Canada. 2008; 30(3): s1-s48.

Lu JF and Nightingale CH. Magnesium Sulfate in Eclampsia and Pre-Eclampsia Pharmacokinetic Principles. Clin Pharmacokinet. 2000; 38(4): 305-314.

Nahar A, Sultana R, Akter FM, Ferdausi M, Yusuf MA, Nahar K. Use Of Misoprostol in Term pregnant women for Good Delivery Outcome: Experience at a tertiary care Hospital in Dhaka. Journal of Science Foundation. 2014; 12(2): 22-26.


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0